Intervention

therascreen® KRAS RGQ PCR Kit

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions3

Lead sponsors shown1

Clinical trials

3 shown

Testing of DNA Extracted From Tumor Tissue Biopsy Samples Using Therascreen KRAS RGQ PCR KitNCT05360225 · 2020-04-02

Clinical Study Testing DNA Extracted From Tumour Tissue Biopsy Samples, Using the Therascreen® KRAS RGQ PCR KitNCT05347797 · 2020-03-13

Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR KitNCT05348187 · 2019-07-01

Common conditions

Non-Small Cell Lung Cancer2 Colorectal Cancer1 Non Small Cell Lung Cancer1

Leading sponsors

QIAGEN Gaithersburg, Inc3

Trial status mix

COMPLETED3

Phase mix

NA2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.